Orthomyxo,paramyxovirus, rubella Flashcards
PICORNAVIRUS
Virion:________ symmetry
Genome :______ sense, _____-stranded (DNA or RNA?) , (linear or circular?) ,
Proteins: ___-___
Envelope: (enveloped or Non-enveloped ?)
Replication: in the _____
lcosahedral
Positive
Single; RNA; linear
VP1 – VP4
Non-enveloped; Cytoplasm
Polio virus
Polio (poliomyelitis) mainly affects children under __ years of age.
5
As long as a single child remains infected, children in all countries are at risk of contracting polio.
T/F
T
Transmission of polio virus
Transmission is ______
Incubation period:____ weeks (range ____ days)
faeco-oral
1 – 2
3 – 35
Polio virus
Capsid shell of ___ subunits
60
Polio virus
(Small or Large?) family of viruses which consist of Enteroviruses and Rhinoviruses.
One of the (smallest or largest?) group of viruses
Large
Smallest
Pathogenesis of polio virus
Primary multiplication takes place in the _______ or _______
The virus first multiplies in the ____, the lymph nodes of the ____, ________ , and the _________
The CNS may then be invaded by way of the _________. Spread along axons of ________ to the CNS
Some cells that lose their function may recover completely
oropharynx or intestine.
tonsils; neck
Peyer patches; small intestine.
circulating blood; peripheral nerves
Polio virus
Virus shedding in stool for _____weeks
6 – 8
SYMPTOMS of polio virus
Mild disease
•Non paralytic polio can cause ___________
•Paralytic polio leads to ______ paralysis resulting from ______ motor neuron damage.
•Progressive post poliomyelitis muscle atrophy as a result of A ______ of _____ and _______ decades after their ________
aseptic meningitis
Acute flaccid ; lower
recrudescence; paralysis and muscle wasting
experience with paralytic poliomyelitis
DIAGNOSIS of polio virus
Specimen- ______,______,____
PCR
Virus culture
Serology
_________________ surveillance
stool, throat swab, CSF
Acute flaccid paralysis (AFP)
MANAGEMENT of polio virus
Treatment: ___________
Supportive care: ______ supplementation, ICU-________, ________ therapy, ______therapy
No specific treatment
Oxygen
ventilation
Occupational; physio
PREVENTION of polio virus
————-,———-
AFP Surveillance, vaccines
Oral polio vaccine
OPV also produces a _______,_________ response in the mucous membrane of the ______.
In the event of infection, these mucosal antibodies _________ inside the intestine.
local, mucosal immune
intestines; limit the replication of the wild poliovirus
Advantages of OPV
• OPV is administered _______, hence It can be given by _____ and does not require _______ or ————
•The vaccine is relatively _______.
OPV is (safe or dangerous?) , _____, and induces (short or long?) -lasting immunity to _______ types of poliovirus.
orally; volunteers
trained health workers or sterile injection equipment.
inexpensive
safe; effective ; long; all three
Disadvantages of OPV
• in extremely rare cases (approx. 1 in every 2.7 million first doses of the vaccine) the _____________ in OPV can ___________
In some cases it is believed that this ________________ (VAPP) may be triggered by ______________
live attenuated vaccine virus
cause paralysis.
vaccine-associated paralytic polio
immune deficiency.
Inactivated polio vaccine
The inactivated polio vaccine produces antibodies in the blood to ____ types of poliovirus
all three
Advantages of IPV
• As IPV is not a ‘live’ vaccine, it carries ____ risk of vaccine- associated polio paralysis.
•IPV triggers _______________ response in most people.
no
an excellent protective immune
Disadvantages of IPV
• IPV induces _____ levels of immunity in the intestine. As a result, when a person immunized with IPV is infected with ____________, the virus can _________ and be _________, risking continued circulation.
•IPV is _______ times more expensive than oral polio vaccine.
Administering the vaccine requires ___________ and _________ and procedures
very low; wild poliovirus; still multiply inside the intestines ; shed in the faeces
over five
trained health workers and sterile injection equipment
Oral polio vaccine (OPV) by _______ in 19__
Inactivated polio vaccine (IPV) by _____ in 19___
Albert Sabin; 61
Jonas Salk; 55
ORTHOMYXOVIRUS
Virion:_____ symmetry , 80 – 120nm
Genome : _____ Stranded RNA,
________ sense
Envelope: ________, containing _________ and ______
Replication: in the _______
Helical; Single
positive; Enveloped
Hemagglutinin and Neuraminidase
Nucleus
Influenza virus
Influenza A virus consist of ____ and _______ strains
human and animal
The _______ and ______ proteins, are used to divide influenza viruses into types ___,___ , and ____
nucleocapsid (NP) and matrix (M)
A, B, and C.
___________ in HA and NA, are used to subtype the influenza viruses. .
Antigenic variations
15 subtypes of HA (H1–H15) and 9 subtypes of NA (N1–N9), in different combinations.
But
___ HA (_______) and ___ NA (_____) subtypes have been recovered from humans.
Four; H1–H3, H5
two; N1, N2
Influenza A(_____) and A(______) subtypes are currently circulating among humans
H1N1
H3N2
Influenza virus
•Antigenic drift
Accumulation of _______ in the gene, resulting in _______ changes in the protein.
Sequence changes can alter ________ on the molecule such that a virion can ___________
point mutations ; amino acid
antigenic sites
escape recognition by the host’s immune system